Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-10.2%
5Y CAGR+22.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-10.2%/yr
Annual compound
5Y CAGR
+22.0%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$45.93M-15.5%
2024$54.34M-17.8%
2023$66.10M+4.2%
2022$63.45M+16.8%
2021$54.32M+219.4%
2020$17.01M-39.4%
2019$28.04M-